⏳ Submissions Close: Friday, 17 July 2026 – 11:59 PM AEST
Decode Science × Bruker × Monash Antibody Discovery Platform
Access the speed and power of Beacon Optofluidic Technology at hybridoma campaign pricing — for antibody discovery and T cell receptor profiling.
2–4 wk
ANTIBODY DISCOVERY
4–6 wk
TCR PROFILING
700 wds
MAX ABSTRACT LENGTH
17 Jul
APPLICATIONS CLOSE
Generating high-quality proof-of-concept antibody data or T cell receptor profiles ahead of a grant cycle or biotech milestone can determine whether a project advances or stalls. Access to cutting-edge single-cell functional screening has historically been limited by cost and infrastructure — until now.
Decode Science, in partnership with Bruker and the Monash Antibody Discovery Platform, is offering two tiers of the Bruker Beacon Grant to support researchers across Australia and New Zealand. Successful applicants gain access to Beacon Optofluidic Technology at the equivalent cost of a traditional hybridoma campaign.
Choose the tier that best matches your institutional affiliation. Both tiers offer the same project scope and technology access.
Equivalent to a traditional hybridoma campaign
Equivalent to a traditional hybridoma campaign
Unsuccessful applicants who are shortlisted will receive 25% off reagents and consumables for their next Beacon project — so every strong application has value.
Bruker’s Beacon platform uses Optofluidic technology to screen and recover single cells with unprecedented speed and precision. Unlike traditional hybridoma workflows, Beacon enables researchers to functionally screen thousands of single B cells or T cells in days — not months — identifying rare, high-value candidates with full sequence recovery.
For antibody discovery, this means accelerated timelines from immunisation to lead candidate. For T cell receptor profiling, it enables direct pairing of TCRα and TCRβ chains from antigen-specific T cells, unlocking high-resolution immune repertoire data.
The Monash Antibody Discovery Platform houses one of Australia’s few Beacon instruments, making this grant a unique opportunity for researchers across ANZ to access this technology without the traditional access barriers.
Applicants must provide their contact details and submit a scientific abstract outlining their proposed project. Your abstract is your opportunity to demonstrate scientific merit and feasibility.
500 – 700 Words
→ Scientific background and rationale for the project
→ Experimental objectives and hypothesis
→ Choice of project type: Antibody Discovery Campaign or T Cell Receptor Profiling
→ Sample type, source, and anticipated availability
→ Expected outcomes and how results will be used
→ Plans for follow-up work or scale-up if the project is successful
Simply add your details below and get quick access to the brochure.
Simply add your details below and get quick access to the brochure.
Simply add your details below and get quick access to the brochure.
